Latest Eisai News & Updates

See the latest news and media coverage for Eisai. We track all announcements, press releases, and industry mentions in real time, all in one place.

Eisai

Human health care company

Latest news about Eisai

April 3 Eisai

Eisai opens new Global Capability Centre

The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.
February 20 Eisai

Eisai receives human capital awards for third year

Eisai earns 'Thought Leaders of Human Capital 2025' and 'Human Capital Management Excellence 2025 Gold Award' for excellent management and disclosure.
January 26 Eisai

Eisai announces FDA acceptance of LEQEMBI IQLIK sBLA

The application for subcutaneous starting dose in early Alzheimer’s is under priority review with action date May 24, 2026.
January 21 Eisai

Eisai ranks 36th in Global 100 sustainability list

It marks Eisai's tenth inclusion and highest rank among global pharmaceutical companies. Evaluation based on UN SDGs, sustainable revenue, and investment.

Today The Globe and Mail

Health Canada approves second drug targeting underlying cause of Alzheimer's disease

Health Canada has approved a second drug that targets the underlying cause of Alzheimer's disease, a development that could give Canadian patients more options to...
April 30 日刊薬業

Application for pulmonary hypertension drug MD-712 in Japan

Motida Pharmaceutical announced on the 30th that it has submitted an approval application to the Ministry of Health, Labour and Welfare for 'MD-712' (development code, generic name = treprostinil), which it has been developing as a treatment for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease...
April 29 Nikkei

Eisai "Lecanemab" sales 88 billion yen, exceeding forecast for FY2026 ending March

Published in conjunction with Biogen's earnings announcement. Sales by major country: US 44.6 billion yen, Japan 24.4 billion yen, China 12.4 billion yen. Eisai's consolidated financial results for FY2026 ending March (IFRS) will be announced on May 15...
April 29 Reuters

Biogen cuts annual profit forecast on acquisition-related charges

Biogen cut its full-year profit forecast on Wednesday as it booked acquisition-related charges, alth...

Never miss news about Eisai

Track Eisai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.